Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials

Detalles Bibliográficos
Autores principales: Golan, Yoav, DuPont, Herbert L, Aldomiro, Fernando, Jensen, Erin H, Hanson, Mary E, Dorr, Mary Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817080/
https://www.ncbi.nlm.nih.gov/pubmed/33511241
http://dx.doi.org/10.1093/ofid/ofaa629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817080/
https://www.ncbi.nlm.nih.gov/pubmed/33511241
http://dx.doi.org/10.1093/ofid/ofaa629

Ejemplares similares